Who is sponsoring NCT06083727?

NCT06083727 is sponsored by Sohag University.

What drugs are being tested in NCT06083727?

Interventions in NCT06083727: rate of cesarean section.

What condition does NCT06083727 study?

NCT06083727 studies Primary Cesarean Section.

Is NCT06083727 still recruiting?

NCT06083727 is currently status unknown. Last updated 16 October 2023.

Last reviewed 2023-10-16 · How we verify

NCT06083727

Name: Drug Landscape Pharmaceutical Database
Creator: Drug Landscape
Published: 2026-01-01
License: https://creativecommons.org/licenses/by/4.0/

Primary Cesarean Section in Primigravida and Muligravida in Sohag and Al Balyana Cities

Status unknown Last updated 16 October 2023

What this trial tests

trial testing rate of cesarean section in Primary Cesarean Section in 100 participants. Status unknown.

Timeline

24 September 2023

Primary endpoint
24 March 2024

24 March 2024

Quick facts

Lead sponsor	Sohag University
Status	Status unknown
Study type	OBSERVATIONAL
Enrollment	100
Start date	24 September 2023
Primary completion	24 March 2024
Estimated completion	24 March 2024
Sites	1 location across Egypt

Drugs / interventions tested

rate of cesarean section

Conditions studied

Primary Cesarean Section — all drugs for Primary Cesarean Section →

Sponsor

Sohag University

Who can join

Adults 18 to 45, female only, with Primary Cesarean Section. Patients with the condition only — healthy volunteers not accepted.

Sponsor's own description

cesarean section and vaginal delivery are two methods of delivery, cesarean section somtimes indicated for obstetrical reason but primary cesarean section especially in primigravida might have a preference of the mode of delivery

Publications & conference data

No peer-reviewed publications indexed yet for this trial.

Verify or expand the search:

Other Sohag University trials

Trials by the same sponsor.

NCT07119905 — Association Between Matrix Metalloproteinase-9 Gene Polymorphism and Susceptibility to Primary Open Angle Glaucoma Patie · not yet recruiting
NCT07512219 — Comparison Between Greater Occipital Nerve Block and Pulsed Radiofrequency in the Management of Chronic Migraine · NA · not yet recruiting
NCT07519694 — Comparative Study Between Different Additives to Lidocaine 2٪ for Peribulbar Block in Vitreoretinal Surgery · NA · not yet recruiting
NCT07515365 — Colitis Patterns in Patients With Lower GI Symptoms · not yet recruiting
NCT07523386 — Compartive Study Between Cannulated Screw and Kws in Fixation of Distal Radius · NA · recruiting

Verify against primary sources

ClinicalTrials.gov — authoritative US registry record
WHO ICTRP — international registry index
EU Clinical Trials Register
Sponsor press releases (Google)

Data sources for this page

Trial protocol + status: ClinicalTrials.gov NCT06083727 (US National Library of Medicine, public domain)
Drug + disease cross-links: matched in real time against Drug Landscape's normalised drug + company + condition tables
Sponsor: as reported to ClinicalTrials.gov by Sohag University
Last refreshed: 16 October 2023

Drug Landscape aggregates and links these public records for informational use only. Always verify against the primary source before clinical or regulatory decisions. Canonical URL: https://druglandscape.com/trial/NCT06083727.

Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing